-
Challenges of combining cytotoxic chemotherapy and tyrosine kinase inhibitors
Michael P Chu, Vijaya L Damaraju & Michael B Sawyer
Perspective: Clinical Investigation
-
Challenges of combining cytotoxic chemotherapy and tyrosine kinase inhibitors
Michael P Chu, Vijaya L Damaraju & Michael B Sawyer
Perspective: Clinical Investigation
-
Challenges of combining cytotoxic chemotherapy and tyrosine kinase inhibitors
Michael P Chu, Vijaya L Damaraju & Michael B Sawyer
Perspective: Clinical Investigation
-
Challenges of combining cytotoxic chemotherapy and tyrosine kinase inhibitors
Michael P Chu, Vijaya L Damaraju & Michael B Sawyer
Perspective: Clinical Investigation
-
Challenges of combining cytotoxic chemotherapy and tyrosine kinase inhibitors
Michael P Chu, Vijaya L Damaraju & Michael B Sawyer
Perspective: Clinical Investigation
-
Challenges of combining cytotoxic chemotherapy and tyrosine kinase inhibitors
Michael P Chu, Vijaya L Damaraju & Michael B Sawyer
Perspective: Clinical Investigation
-
Challenges of combining cytotoxic chemotherapy and tyrosine kinase inhibitors
Michael P Chu, Vijaya L Damaraju & Michael B Sawyer
Perspective: Clinical Investigation
-
Challenges of combining cytotoxic chemotherapy and tyrosine kinase inhibitors
Michael P Chu, Vijaya L Damaraju & Michael B Sawyer
Perspective: Clinical Investigation
-
New strategies for the treatment of inflammatory bowel diseases
Xavier Roblin, William Dronne, Stephane Paul, Emilie Del Tedesco
Review: Clinical Trail Outcomes: Clinical Investigation
-
New strategies for the treatment of inflammatory bowel diseases
Xavier Roblin, William Dronne, Stephane Paul, Emilie Del Tedesco
Review: Clinical Trail Outcomes: Clinical Investigation
-
New strategies for the treatment of inflammatory bowel diseases
Xavier Roblin, William Dronne, Stephane Paul, Emilie Del Tedesco
Review: Clinical Trail Outcomes: Clinical Investigation
-
New strategies for the treatment of inflammatory bowel diseases
Xavier Roblin, William Dronne, Stephane Paul, Emilie Del Tedesco
Review: Clinical Trail Outcomes: Clinical Investigation
-
New strategies for the treatment of inflammatory bowel diseases
Xavier Roblin, William Dronne, Stephane Paul, Emilie Del Tedesco
Review: Clinical Trail Outcomes: Clinical Investigation
-
New strategies for the treatment of inflammatory bowel diseases
Xavier Roblin, William Dronne, Stephane Paul, Emilie Del Tedesco
Review: Clinical Trail Outcomes: Clinical Investigation
-
New strategies for the treatment of inflammatory bowel diseases
Xavier Roblin, William Dronne, Stephane Paul, Emilie Del Tedesco
Review: Clinical Trail Outcomes: Clinical Investigation
-
New strategies for the treatment of inflammatory bowel diseases
Xavier Roblin, William Dronne, Stephane Paul, Emilie Del Tedesco
Review: Clinical Trail Outcomes: Clinical Investigation
-
Design, findings and implications of the liraglutide Phase III clinical trial program
Bruce W Bode
Review: Clinical Trail Outcomes: Clinical Investigation
-
Design, findings and implications of the liraglutide Phase III clinical trial program
Bruce W Bode
Review: Clinical Trail Outcomes: Clinical Investigation
-
Design, findings and implications of the liraglutide Phase III clinical trial program
Bruce W Bode
Review: Clinical Trail Outcomes: Clinical Investigation
-
Design, findings and implications of the liraglutide Phase III clinical trial program
Bruce W Bode
Review: Clinical Trail Outcomes: Clinical Investigation
-
Design, findings and implications of the liraglutide Phase III clinical trial program
Bruce W Bode
Review: Clinical Trail Outcomes: Clinical Investigation
-
Design, findings and implications of the liraglutide Phase III clinical trial program
Bruce W Bode
Review: Clinical Trail Outcomes: Clinical Investigation
-
Design, findings and implications of the liraglutide Phase III clinical trial program
Bruce W Bode
Review: Clinical Trail Outcomes: Clinical Investigation
-
Design, findings and implications of the liraglutide Phase III clinical trial program
Bruce W Bode
Review: Clinical Trail Outcomes: Clinical Investigation
-
Clinical trials of systemic therapy in osteosarcoma and Ewing\\\'s sarcoma: past, present and future
R Grant Rowe, Rashmi Chugh
Review Article: Clinical Investigation
-
Clinical trials of systemic therapy in osteosarcoma and Ewing\\\'s sarcoma: past, present and future
R Grant Rowe, Rashmi Chugh
Review Article: Clinical Investigation
-
Clinical trials of systemic therapy in osteosarcoma and Ewing\\\'s sarcoma: past, present and future
R Grant Rowe, Rashmi Chugh
Review Article: Clinical Investigation
-
Clinical trials of systemic therapy in osteosarcoma and Ewing\\\'s sarcoma: past, present and future
R Grant Rowe, Rashmi Chugh
Review Article: Clinical Investigation
-
Clinical trials of systemic therapy in osteosarcoma and Ewing\\\'s sarcoma: past, present and future
R Grant Rowe, Rashmi Chugh
Review Article: Clinical Investigation
-
Clinical trials of systemic therapy in osteosarcoma and Ewing\\\'s sarcoma: past, present and future
R Grant Rowe, Rashmi Chugh
Review Article: Clinical Investigation
-
Clinical trials of systemic therapy in osteosarcoma and Ewing\\\'s sarcoma: past, present and future
R Grant Rowe, Rashmi Chugh
Review Article: Clinical Investigation
-
Clinical trials of systemic therapy in osteosarcoma and Ewing\\\'s sarcoma: past, present and future
R Grant Rowe, Rashmi Chugh
Review Article: Clinical Investigation
-
Emerging treatments for small-cell lung cancer: Phase II and III trials
Joel W Neal, Matthew A Gubens, Heather A Wakelee
Review Article: Clinical Investigation
-
Emerging treatments for small-cell lung cancer: Phase II and III trials
Joel W Neal, Matthew A Gubens, Heather A Wakelee
Review Article: Clinical Investigation
-
Emerging treatments for small-cell lung cancer: Phase II and III trials
Joel W Neal, Matthew A Gubens, Heather A Wakelee
Review Article: Clinical Investigation
-
Emerging treatments for small-cell lung cancer: Phase II and III trials
Joel W Neal, Matthew A Gubens, Heather A Wakelee
Review Article: Clinical Investigation
-
Emerging treatments for small-cell lung cancer: Phase II and III trials
Joel W Neal, Matthew A Gubens, Heather A Wakelee
Review Article: Clinical Investigation
-
Emerging treatments for small-cell lung cancer: Phase II and III trials
Joel W Neal, Matthew A Gubens, Heather A Wakelee
Review Article: Clinical Investigation
-
Emerging treatments for small-cell lung cancer: Phase II and III trials
Joel W Neal, Matthew A Gubens, Heather A Wakelee
Review Article: Clinical Investigation
-
Emerging treatments for small-cell lung cancer: Phase II and III trials
Joel W Neal, Matthew A Gubens, Heather A Wakelee
Review Article: Clinical Investigation